Parkinson's Disease: Animal Models

Parkinson’s disease is a progressive neurodegenerative disorder that affects movement. This feed focuses on Parkinson's disease research using animal models.

January 21, 2022

Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite.

Proceedings of the National Academy of Sciences of the United States of America
Isaac P HeremansGuido T Bommer
January 21, 2022
Open Access

Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease.

Frontiers in Neurology
Eduard LinetskyDavid Arkadir
January 21, 2022
Open Access

Metaheuristics with Deep Learning-Enabled Parkinson's Disease Diagnosis and Classification Model.

Journal of Healthcare Engineering
Adel A BahaddadEied M Khalil
January 21, 2022

α-Synuclein Aggregation Inhibitory Prunolides and a Dibrominated β-Carboline Sulfamate from the Ascidian Synoicum prunum.

Journal of Natural Products
Darren C HollandAnthony R Carroll
January 21, 2022

Physical exercise influences astrocytes in the striatum of a Parkinson's disease male mouse model.

Neuroscience Letters
Louise Caroline VitorinoClynton Lourenço Correa
January 20, 2022
Open Access

Re-routing metabolism by the mitochondrial pyruvate carrier inhibitor MSDC-0160 attenuates neurodegeneration in a rat model of Parkinson's disease

BioRxiv : the Preprint Server for Biology
D. MalletSabrina Boulet
January 20, 2022

Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1α in a Mouse Model of Parkinson's Disease.

Neurotoxicity Research
Pengyue WuYanqin Wang
January 19, 2022
Open Access

Idebenone improves motor dysfunction, learning and memory by regulating mitophagy in MPTP-treated mice.

Cell Death Discovery
Junqiang YanJiannan Wu
January 19, 2022

Levodopa-induced dyskinesia: a historical review of Parkinson's disease, dopamine, and modern advancements in research and treatment.

Journal of Neurology
Carissa A HansenHabibeh Khoshbouei
January 19, 2022

Drosophila: A Model to Study the Pathogenesis of Parkinson's Disease.

CNS & Neurological Disorders Drug Targets
Rahul, Yasir Hasan Siddique
January 17, 2022

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model.

Journal of Visualized Experiments : JoVE
Naemah Md HamzahKalavathy Ramasamy
January 17, 2022

Chronic Alcohol Exposure Alters Gene Expression and Neurodegeneration Pathways in the Brain of Adult Mice.

Journal of Alzheimer's Disease : JAD
Mingjing LiuWeihong Song
January 17, 2022

T cells, α-synuclein and Parkinson disease.

Handbook of Clinical Neurology
Francesca GarrettiDavid Sulzer
January 17, 2022

Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease.

Handbook of Clinical Neurology
Gioia MarinoVeronica Ghiglieri
January 17, 2022

Parkinson's disease: Alterations of motor plasticity and motor learning.

Handbook of Clinical Neurology
Kaviraja UdupaRobert Chen
January 16, 2022

Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice.

Brain, Behavior, and Immunity
Akua A KarikariChi Wang Ip

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved